DNA Methylation Profiles and Breast Cancer among WTC Survivors


Project Number
1 R21 OH012238-01
Institution
NYU School of Medicine
Fiscal Year Awarded
2021
Project Duration
2 year

Description

The main objective of the project is to assess and validate the role of DNA methylation as objective marker of WTC exposure-related breast cancer among general population of survivors, specifically women.

 

Study Design: Case-control study

Publications

No publications available at this time.

No image provided for Principle Investigator
Principal Investigator: Alan Arslan, MD
NYU School of Medicine
alan.arslan@nyulangone.org
(212) 263-7763